• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

C反应蛋白浓度作为急性白血病抗生素治疗的指导指标

C-reactive protein concentration as a guide to antibiotic therapy in acute leukaemia.

作者信息

Schofield K P, Voulgari F, Gozzard D I, Leyland M J, Beeching N J, Stuart J

出版信息

J Clin Pathol. 1982 Aug;35(8):866-9. doi: 10.1136/jcp.35.8.866.

DOI:10.1136/jcp.35.8.866
PMID:7107959
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC497805/
Abstract

Serial monitoring of the serum C-reactive protein (CRP) concentration was performed, using a one-hour laser-immunonephelometric assay, during 29 episodes of infection in 22 neutropenic patients with acute leukaemia. Serum CRP increased to above a diagnostic level of 100 mg/l in all 29 episodes and continued to rise progressively until appropriate antibiotics, or granulocytes, were given when it fell with a half-life of approximately three days. Serial study of the serum concentration was of value in detecting occult or unresolved bacterial infection and provided an objective means of monitoring the response to antibiotic and granulocyte therapy.

摘要

采用一小时激光免疫比浊法,对22例急性白血病中性粒细胞减少患者的29次感染发作进行血清C反应蛋白(CRP)浓度的连续监测。在所有29次感染发作中,血清CRP均升高至诊断水平100mg/L以上,并持续逐渐上升,直至给予适当的抗生素或粒细胞后,其以约三天的半衰期下降。血清浓度的连续研究对于检测隐匿性或未解决的细菌感染具有价值,并提供了一种监测对抗生素和粒细胞治疗反应的客观方法。

相似文献

1
C-reactive protein concentration as a guide to antibiotic therapy in acute leukaemia.C反应蛋白浓度作为急性白血病抗生素治疗的指导指标
J Clin Pathol. 1982 Aug;35(8):866-9. doi: 10.1136/jcp.35.8.866.
2
Serial study of C-reactive protein during infection in leukaemia.白血病感染期间C反应蛋白的系列研究
J Clin Pathol. 1981 Mar;34(3):263-6. doi: 10.1136/jcp.34.3.263.
3
C-reactive protein for detection and follow-up of bacterial and fungal infections in severely neutropenic patients with acute leukaemia.C反应蛋白用于急性白血病严重中性粒细胞减少患者细菌和真菌感染的检测及随访
Eur J Cancer Clin Oncol. 1985 May;21(5):557-62. doi: 10.1016/0277-5379(85)90080-x.
4
Serum C-reactive protein levels in the management of infection in acute leukaemia.血清C反应蛋白水平在急性白血病感染管理中的作用
Eur J Cancer Clin Oncol. 1984 Mar;20(3):319-25. doi: 10.1016/0277-5379(84)90076-2.
5
C-reactive protein: a valuable aid for the management of febrile children with cancer and neutropenia.C反应蛋白:对患有癌症和中性粒细胞减少症的发热儿童进行管理的一项重要辅助指标
Clin Infect Dis. 1994 Apr;18(4):589-95. doi: 10.1093/clinids/18.4.589.
6
Infections in acute leukaemia.急性白血病中的感染
J Assoc Physicians India. 1992 Jan;40(1):36-9.
7
The management of febrile episodes in-neutropenic cancer.
Med J Aust. 1977 Apr 2;1(14):473-5.
8
Asymptomatic C-reactive protein elevation in neutropenic children.中性粒细胞减少儿童的无症状C反应蛋白升高
Pediatr Int. 2017 Jan;59(1):23-28. doi: 10.1111/ped.13077. Epub 2016 Sep 21.
9
Granulocyte transfusions as a therapy and a prophylaxis of infections in neutropenic patients.粒细胞输注作为中性粒细胞减少患者感染的一种治疗和预防方法。
Eur J Cancer (1965). 1979;15 Suppl:15-22.
10
[C-reactive protein concentrations during initial (empiric) treatment of neonatal sepsis].新生儿败血症初始(经验性)治疗期间的C反应蛋白浓度
Srp Arh Celok Lek. 2001 May-Jun;129 Suppl 1:17-22.

引用本文的文献

1
Haptoglobin in Juvenile Idiopathic Arthritis.青少年特发性关节炎中的触珠蛋白。
Pediatr Rheumatol Online J. 2022 Dec 15;20(1):117. doi: 10.1186/s12969-022-00777-5.
2
Longitudinal trajectory patterns of plasma albumin and C-reactive protein levels around diagnosis, relapse, bacteraemia, and death of acute myeloid leukaemia patients.急性髓系白血病患者在确诊、复发、菌血症和死亡前后的血浆白蛋白和 C 反应蛋白水平的纵向轨迹模式。
BMC Cancer. 2020 Mar 24;20(1):249. doi: 10.1186/s12885-020-06754-z.
3
C-reactive protein and alpha 1-acid glycoprotein levels in dogs infected with Ehrlichia canis.感染犬埃立克体的犬的C反应蛋白和α1-酸性糖蛋白水平
J Clin Microbiol. 1994 Apr;32(4):912-7. doi: 10.1128/jcm.32.4.912-917.1994.
4
C-reactive protein as an indicator of resolution of sepsis in the intensive care unit.
Intensive Care Med. 1995 Jul;21(7):602-5. doi: 10.1007/BF01700168.
5
C-reactive protein in patients with bacteremia.菌血症患者体内的C反应蛋白
J Clin Microbiol. 1984 Sep;20(3):317-9. doi: 10.1128/jcm.20.3.317-319.1984.
6
C reactive protein rapid assay techniques for monitoring resolution of infection in immunosuppressed patients.用于监测免疫抑制患者感染消退情况的C反应蛋白快速检测技术。
J Clin Pathol. 1984 Jul;37(7):821-5. doi: 10.1136/jcp.37.7.821.
7
Value of serum C-reactive protein measurement in the management of bone marrow transplant recipients. Part I: Early transplant period.血清C反应蛋白检测在骨髓移植受者管理中的价值。第一部分:移植早期。
J Clin Pathol. 1984 Sep;37(9):1018-21. doi: 10.1136/jcp.37.9.1018.
8
Measurement of serum C reactive protein concentration after bone marrow transplantation for leukaemia.白血病骨髓移植后血清C反应蛋白浓度的测定
J Clin Pathol. 1984 Mar;37(3):263-6. doi: 10.1136/jcp.37.3.263.
9
C reactive protein in the evaluation of febrile illness.C反应蛋白在发热性疾病评估中的应用
Arch Dis Child. 1986 Jan;61(1):24-9. doi: 10.1136/adc.61.1.24.
10
Serial concentrations of C-reactive protein as an indicator of urinary tract infection in patients with spinal injury.连续测定C反应蛋白浓度作为脊髓损伤患者尿路感染的指标
J Clin Pathol. 1986 Aug;39(8):851-5. doi: 10.1136/jcp.39.8.851.

本文引用的文献

1
Efficiency of haematological screening tests for detecting disease.血液学筛查检测在疾病检测中的效率。
Clin Lab Haematol. 1981;3(4):299-305.
2
Serial study of C-reactive protein during infection in leukaemia.白血病感染期间C反应蛋白的系列研究
J Clin Pathol. 1981 Mar;34(3):263-6. doi: 10.1136/jcp.34.3.263.
3
Granulocyte transfusions: where now?粒细胞输注:现状如何?
N Engl J Med. 1981 Sep 10;305(11):636-8. doi: 10.1056/NEJM198109103051109.
4
C-reactive protein fifty years on.五十年后的C反应蛋白。
Lancet. 1981 Mar 21;1(8221):653-7. doi: 10.1016/s0140-6736(81)91565-8.
5
Rabbit CRP response to endotoxin administration: dose-response relationship and kinetics.兔子对注射内毒素的C反应蛋白反应:剂量反应关系及动力学
Proc Soc Exp Biol Med. 1974 Sep;146(4):1132-6. doi: 10.3181/00379727-146-38260.
6
The liver as the site of C-reactive protein formation.肝脏作为C反应蛋白的形成部位。
J Exp Med. 1966 Feb 1;123(2):365-78. doi: 10.1084/jem.123.2.365.